Go implant-free in de novo lesions: DCB-only strategy

Sponsored by B. Braun Melsungen AG

Chairpersons: R. Byrne, B. Scheller
Panellists: S. Eccleshall, F. Kleber
SHOW MORE

Summary

Consult this session to learn about the DCB-only concept, treatment methodology and consensus group recommendations, and discover the latest scientific evidence of DCB-only in de novo lesions and in complex PCIs.

Learning Objectives

  • To learn about the DCB-only concept, treatment methodology and consensus group recommendations
  • To acquire skills about application and safety aspects of the DCB-only approach
  • To discuss latest scientific evidence of DCB-only in de novo lesions and in complex PCIs